Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab is a research paper published in Allergy (2021). On theSindex it has a DataRank of 1.0. It has been cited 34 times, with 21 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.533
From this paper's citation signal
Citation Network Contribution
0.482
From 17 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 21 citers.
National Institutes of Health
Grant: 5T32AI007512
National Institutes of Health
Grant: 5UM2AI130836‐04
National Institutes of Health
Grant: R01AI119918
National Institutes of Health
Grant: R01AI140134‐02
National Institutes of Health
Grant: U01 AI140498‐03
National Institutes of Health
Grant: U19AI104209
NIAID NIH HHS
Grant: T32 AI007512
NIAID NIH HHS
Grant: R01 AI140134
NIH HHS
Grant: 5UM2AI130836-04
NIAID NIH HHS
Grant: U01 AI147462
NIAID NIH HHS
Grant: U01 AI140498
NIH HHS
Grant: U01 AI140498-03
NIH HHS
Grant: R01AI140134-02
NIAID NIH HHS
Grant: UM2 AI130836
Simons Foundation
FWCI
3.78
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords